Vincenzo Di Nunno, Enrico Franceschi, Alicia Tosoni, Monica Di Battista, Lidia Gatto, Cinzia Lamperini, Santino Minichillo, Antonella Mura, Stefania Bartolini, Alba A Brandes
Expert review of anticancer therapy 2020 SepAlmost all patients affected by glioblastoma experience recurrence of the disease. Management of recurrent glioblastoma is a clinical challenge, and several elements should be taken into consideration when making treatment choice. Loco-regional treatments may be the best treatment approach in selected cases while systemic therapies or supportive care alone are necessary for other patients. Unfortunately, few drugs have shown clinical in this setting. This lack of effective treatments has made recurrent glioblastoma a disease orphan of an effective approach. Results of recent clinical trials offer interesting perspectives and may controvert this axiom.
Vincenzo Di Nunno, Enrico Franceschi, Alicia Tosoni, Monica Di Battista, Lidia Gatto, Cinzia Lamperini, Santino Minichillo, Antonella Mura, Stefania Bartolini, Alba A Brandes. Treatment of recurrent glioblastoma: state-of-the-art and future perspectives. Expert review of anticancer therapy. 2020 Sep;20(9):785-795
PMID: 32799576
View Full Text